JCR Pharmaceuticals Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares JCR Pharmaceuticals Co., Ltd. with three other
pharmaceutical manufacturers in Asia:
Shilpa Medicare Limited
sales of 7.79 billion Indian Rupees [US$120.96 million]
Sms Pharmaceuticals Limited
(6.54 billion Indian Rupees [US$101.52 million]
J B Chemicals and Pharmaceuticals Ltd
based in India
(13.68 billion Indian Rupees [US$212.50 million]
JCR Pharmaceuticals Co., Ltd. reported sales of ¥18.09 billion (US$162.58 million)
March of 2017.
increase of 3.7%
versus 2016, when the company's sales were ¥17.44 billion.
Sales at JCR Pharmaceuticals Co., Ltd. have increased during each of the previous five years
(and since 2012, sales have increased a total of 41%).
Sales of Pharmaceutical Business saw an increase
3.7% in 2017, from
¥17.04 billion to ¥17.68 billion.